Baker Institute Seminar Series – Dr. Dina Tresnan
Dr. Dina Tresnan will be presenting “A glimpse into the journey of a veterinarian scientist in the biopharma industry”
Dina B. Tresnan, DVM, PhD
Dina is currently Program Director, Senior Director, Vaccines Development Management at Pfizer, where she leads cross-functional teams responsible for Vaccine development. Dina earned her BSc from Stanford University, Stanford, CA; DVM from the University of California-Davis, Davis, CA and a PhD in molecular virology from Cornell University, Ithaca, NY (in Colin Parrish’s lab). She is a Diplomate of the American College of Veterinary Microbiology (boarded in Virology and Immunology) and a member of their Biosecurity Task Force. Previously she led a group of healthcare professionals in Safety Surveillance and Risk Management in Worldwide Safety at Pfizer, where she directed the pharmacovigilance and development, implementation, and evaluation of global risk management strategies aimed at achieving optimum benefit-risk for medicinal products throughout their lifecycle, with a particular interest in vaccines, biotherapeutics and advanced medicinal therapies. Most recently she led a group of Safety Risk Leads (SRL) supporting Immuno-Oncology programs as well as was SRL for the development of the COVID-19 mRNA Vaccine and original submissions. Prior to that she supported programs in early development in Vaccines, Oncology and Rare Diseases and was a Disease Area Head managing a group of safety risk leads/physicians globally to support pharmacovigilance and risk management deliverables for a broad portfolio including vaccines, large and small molecule medicines, innovative and established products, devices, and Rx to OTC switches. Other roles at Pfizer include Intellectual Property Lifecycle Management and Planning in the Legal Division and Project Leader in Animal Health Biologicals. Prior to Pfizer, Dina worked in various labs studying the regulation of immune responses, as well as viral pathogenesis and host cell tropism, as an assistant professor of Microbiology at the University of Colorado Health Sciences Center and in laboratories at the Baker Institute (Doug Antczak), Stanford University Medical Center and the DNAX Research Institute.
